|
[1] RAZUMILAVA N, GORES GJ. Cholangiocarcinoma[J]. Lancet, 2014, 383(9935):2168-2179.
|
|
[2] YAN X, HU Z, FENG Y, et al. Comprehensive genomic characterization of long non-coding RNAs across human cancers[J]. Cancer Cell, 2015, 28(4):529-540.
|
|
[3] XU H, ZHOU M, CAO Y, et al. Genome-wide analysis of long noncoding RNAs, microRNAs, and mRNAs forming a competing endogenous RNA network in repeated implantation failure[J]. Gene, 2019, 720:144056.
|
|
[4] RANSOHOFF JD, WEI Y, KHAVARI PA. The functions and unique features of long intergenic non-coding RNA[J]. Nat Rev Mol Cell Biol, 2018, 19(3):143-157.
|
|
[5] QUINN JJ, CHANG HY. Unique features of long non-coding RNA biogenesis and function[J]. Nat Rev Genet, 2016, 17(1):47-62.
|
|
[6] DENIZ E, ERMAN B. Long noncoding RNA(lincRNA), a new paradigm in gene expression control[J]. Funct Integr Genomics, 2017, 17(2-3):135-143.
|
|
[7] AHN KS, KANG KJ, KIM YH, et al. Genetic features associated with(18)F-FDG uptake in intrahepatic cholangiocarcinoma[J]. Ann Surg Treat Res, 2019, 96(4):153-161.
|
|
[8] SUBRAMANIAN A, TAMAYO P, MOOTHA VK, et al. Gene set enrichment analysis:A knowledge-based approach for interpreting genome-wide expression profiles[J]. Proc Natl Acad Sci U S A, 2005, 102(43):15545-15550.
|
|
[9] CHEN XP, XIANG S. Therapy of hilar cholangiocarcinoma in the precise medicine period[J]. Chin J Surg, 2018, 17(1):3-8.(in Chinese）陈孝平，项帅．精准医学时代肝门部胆管癌的治疗[J]．中华消化外科杂志，2018, 17(1):3-8.
|
|
[10] CABILI MN, TRAPNELL C, GOFF L, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses[J]. Genes Dev, 2011, 25(18):1915-1927.
|
|
[11] IYER MK, NIKNAFS YS, MALIK R, et al. The landscape of long noncoding RNAs in the human transcriptome[J]. Nat Genet, 2015, 47(3):199-208.
|
|
[12] WINKLE M, KLUIVER JL, DIEPSTRA A, et al. Emerging roles for long noncoding RNAs in B-cell development and malignancy[J]. Crit Rev Oncol Hematol, 2017, 120:77-85.
|
|
[13] GOYAL N, KESHARWANI D, DATTA M. Lnc-ing non-coding RNAs with metabolism and diabetes:Roles of lncRNAs[J]. Cell Mol Life Sci, 2018, 75(10):1827-1837.
|
|
[14] ZHANG B, GUNAWARDANE L, NIAZI F, et al. A novel RNA motif mediates the strict nuclear localization of a long noncoding RNA[J]. Mol Cell Biol, 2014, 34(12):2318-2329.
|
|
[15] YIN HZ, GUO HL, PEI Y, et al. Research progress of long noncoding RNA in primary liver cancer[J]. China Med Herald,2019, 16(20):34-37.(in Chinese）殷宏振，郭化磊，裴颖，等．长链非编码RNA在原发性肝癌中的研究进展[J]．中国医药导报，2019, 16(20):34-37.
|
|
[16] CAI Y, YAN P, ZHANG G, et al. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFalpha[J]. Cancer Biomark, 2018, 23(1):145-156.
|
|
[17] LU XW, XU N, ZHENG YG, et al. Increased expression of long noncoding RNA LINC00961 suppresses glioma metastasis and correlates with favorable prognosis[J]. Eur Rev Med Pharmacol Sci, 2018, 22(15):4917-4924.
|
|
[18] ZHANG J, JU C, ZHANG W, et al. LncRNA SNHG20 is associated with clinical progression and enhances cell migration and invasion in osteosarcoma[J]. IUBMB Life, 2018, 70(11):1115-1121.
|
|
[19] TANG L, WANG Y, WANG H, et al. Long noncoding-RNA component of mitochondrial RNA processing endoribonuclease is involved in the progression of cholangiocarcinoma by regulating microRNA-217[J]. Cancer Sci, 2019, 110(7):2166-2179.
|
|
[20] LI Y, CAI Q, LI W, et al. Long non-coding RNA EPIC1 promotes cholangiocarcinoma cell growth[J]. Biochem Biophys Res Commun, 2018, 504(4):654-659.
|
|
[21] DENG M, SUN J, XIE S, et al. Inhibition of MCM2 enhances the sensitivity of ovarian cancer cell to carboplatin[J]. Mol Med Rep, 2019, 20(3):2258-2266.
|
|
[22] TOKES T, TOKES AM, SZENTMARTONI G, et al. Prognostic and clinicopathological correlations of cel cycle marker expressions before and after the primary systemic therapy of breast cancer[J]. Pathol Oncol Res, 2019.[Online ahead of print]
|
DownLoad: